Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Instituto de Investigación Biomédica de Salamanca
With
Carlos III Health Institute
Age
12–35
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with a diagnosis of first-episode psychosis, either non-affective or affective.
Patients aged 12-35 years.
Patients followed by clinical services for at least one year, or earlier if there was evidence of antipsychotic treatment discontinuation.
For cohort one: Patients and/or their family or legal representatives must provide written consent to take part in the CLUMP Project, including pharmacogenetics analysis.
For cohort two: This will not be a mandatory inclusion criterion, but all patients will be approached by our research team seeking their consent to obtain their pharmacogenetic profile for research purposes.
You may not be if
Patients with first-episode psychosis due to organic causes, for example, brain diseases such as Huntington's and Parkinson's disease, HIV, syphilis, dementia, brain tumours or cysts, or brain injury.
Patients with moderate to severe intellectual disability.
Patients who plan to reside (cohort one) or spent (cohort two) most of the one-year follow-up period in a locality outside of the PRINT's catchment area.
Clareo Health | CLinical Utility of Early Intervention Including the 5-Step Precision Medicine (5SPM) Method in First-episode Psychosis: The CLUMP Project
